Proof of efficacy of nootropics for the indication "dementia" (phase III)--recommendations.
Menges
K
K
Institut für Arzneimittel, Berlin, Germany.
D006801:Humans; D009422:Nervous System Diseases / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D012107:Research Design
D011619:Psychotropic Drugs